Cancer Research UK logo.
SearchDonate
  • Search

A trial of nivolumab and ipilimumab for small cell lung cancer that has spread (CA209451)

Overview

Cancer types:

Lung cancer, Small cell lung cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at whether giving immunotherapy can delay or prevent small cell lung cancer (SCLC) coming back after first treatment. It is for people with SCLC that has spread to another part of the body.

Recruitment start: 13 October 2015

Recruitment end: 8 September 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Martin David Forster

Supported by

Bristol-Myers Squibb

Last reviewed: 12 September 2017

CRUK internal database number: 13771

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.